Afraceuticals is thrilled to share our latest update: PELAFORCE™ is now officially registered as a licensed natural health product with Health Canada.
PELAFORCE™ now appears within the Licensed Natural Health Products Database, which is managed by Health Canada. This database stores information about natural health products that have been issued a product licence by Health Canada. Licensed natural health products can be identified by looking for their eight-digit NPN (Natural Product Number) on the label.
In order to obtain our licence, PELAFORCE™ was assessed by Health Canada. This rigorous assessment showed PELAFORCE™, when used under their recommended directions, to be:
· SAFE
· EFFECTIVE, and
· OF HIGH QUALITY.
As per our product licence, PELAFORCE’s use / purpose is as follows:
Helps to reduce/relieve the symptoms of upper respiratory tract infections (e.g., common colds). Helps to provide symptomatic relief from/reduce symptom severity of bronchitis, laryngitis, pharyngitis, and/or the common cold (in children, adolescents, and/or adults). Helps to relieve symptoms (of cough, runny nose, sore throat, sputum, and/or chest pain from coughing) associated with bronchitis, laryngitis, pharyngitis, and/or the common cold (in children, adolescents, and/or adults). Helps to reduce the recovery time from/duration of bronchitis, laryngitis, pharyngitis, and/or the common cold (in children, adolescents, and/or adults). Helps to reduce/relieve the symptoms associated with bronchitis and upper respiratory tract infections (e.g., common colds) Helps to reduce/relieve the symptoms (cough, runny nose, sputum, and/or chest pain from coughing) associated with upper respiratory tract infections (e.g., common colds).
For more information about the Licensed Natural Health Products Database: https://www.canada.ca/en/health-canada/services/drugs-health-products/natural-non-prescription/applications-submissions/product-licensing/licensed-natural-health-products-database.html
For more information about Afraceuticals and PELAFORCE™: www.afraceuticals.com
Comments